Beximco Pharmaceuticals (DHA:BXPHARMA) Construction In Progress : BDT0 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Construction In Progress?

Beximco Pharmaceuticals's quarterly construction in progress declined from Jun. 2023 (BDT1,847 Mil) to Dec. 2023 (BDT0 Mil) but then stayed the same from Dec. 2023 (BDT0 Mil) to Mar. 2024 (BDT0 Mil).

Beximco Pharmaceuticals's annual construction in progress declined from Jun. 2021 (BDT16,507 Mil) to Jun. 2022 (BDT835 Mil) but then increased from Jun. 2022 (BDT835 Mil) to Jun. 2023 (BDT1,847 Mil).

Beximco Pharmaceuticals Construction In Progress Historical Data

The historical data trend for Beximco Pharmaceuticals's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Construction In Progress Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Construction In Progress

Get a 7-Day Free Trial

13,753.11

15,789.47

16,507.44

834.68

1,847.06

Beximco Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															-	-	1,847.06	-	-

Beximco Pharmaceuticals Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Construction In Progress

Traded in Other Exchanges

BXP:UK R2WA:Germany

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines